Published studies also indicated that non-EpCAM expressing cell may comprise the majority of CTC in NSCLC peripheral blood, and thus EpCAM based enrichment may fail to detect rare CTC [22]. This evidence concerns the gene EPCAM and non-small cell lung carcinoma.